Please Wait.....

Report

Global Pharmacogenetics Testing in Psychiatry Depression Market

Market Report I 2024-02-01 I 565 Pages I Data Bridge Market Research

The global pharmacogenetics testing in psychiatry/depression market is expected to reach USD 2,664,382.70 thousand by 2031 from USD 1,224,473.84 thousand in 2023, growing with a CAGR of 10.4% in the forecast period of 2024 to 2034.
Market Segmentation
Global Pharmacogenetics Testing in Psychiatry/Depression Market, By Type (Anxiety, Mood Disorders, Depression, Bipolar Disorders, Psychotic Disorders, and Eating Disorders), Test Type (Whole Genome Sequencing and Chromosomal Array-Based Tests), Patient Type (Child, Adults, and Geriatric), Gene Type (CYP2C19, CYP2C9 and VKORC1, CYP2D6, HLA-B, HTR2A/C, HLA-A, CYP3A4, SLC6A4, MTHFR, COMT, and Others), Products (Instruments, Consumables, and Software and Services), End User (Hospitals and Clinics, Diagnostics Laboratories, Academic and Research Institutes, and Others), Distribution Channel (Direct Tender, Third Party Distribution, Hospital Pharmacy, and Others), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Russia, Spain, Turkey, Belgium, Netherlands, Switzerland, Denmark, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Indonesia, Philippines, Malaysia, New Zealand, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2031

Overview of Global Pharmacogenetics Testing in Psychiatry/Depression Market Dynamics

Driver
- Rising number of population suffering from depressive disorder
Restraint

- Insufficient clinical validation

Opportunity

- Advancements in genetic testing

Market Players

Some of the major market players operating in the global pharmacogenetics testing in psychiatry/depression market are listed below:

- ThermoFisher Scientific Inc. (U.S.)
- Illumina Inc. (U.S.)
- Myriad Genetics Inc. (U.S.)
- Sonic Healthcare Limited (Australia)
- QIAGEN (Germany)
- AB-BIOTICS S.A. (Spain)
- BiogeniQ Inc. (Canada)
- Castle Bioscience Inc. (U.S.)
- Coriell Life Sciences (U.S.)
- Dynamic DNA Laboratories (U.S.)
- Eurofins Scientific (Luxembourg)
- Genelex (U.S.)
- Genewiz (U.S.)
- Genomind Inc. (U.S.)
- GenXys (Canada)
- HealthSpek (U.S.)
- HudsonAlpha (U.S.)
- MD Labs (U.S.)
- ONEOME LLC (U.S.)
- PacBio (U.S.)

TABLE OF CONTENTS
1 INTRODUCTION 62
1.1 OBJECTIVES OF THE STUDY 62
1.2 MARKET DEFINITION 62
1.3 OVERVIEW OF GLOBAL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET 62
1.4 CURRENCY AND PRICING 64
1.5 LIMITATIONS 64
1.6 MARKETS COVERED 65
2 MARKET SEGMENTATION 70
2.1 MARKETS COVERED 70
2.2 GEOGRAPHICAL SCOPE 71
2.3 YEARS CONSIDERED FOR THE STUDY 72
2.4 DBMR TRIPOD DATA VALIDATION MODEL 73
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 76
2.6 MULTIVARIATE MODELLING 77
2.7 MARKET END USER COVERAGE GRID 78
2.8 TYPE LIFELINE CURVE 79
2.9 DBMR MARKET POSITION GRID 80
2.10 VENDOR SHARE ANALYSIS 82
2.11 SECONDARY SOURCES 83
2.12 ASSUMPTIONS 83
3 EXECUTIVE SUMMARY 84
4 PREMIUM INSIGHT 88
4.1 PESTAL ANALYSIS 90
4.2 PORTERS FIVE FORCES 91
5 INDUSTRIAL INSIGHTS 92
6 GLOBAL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, REGULATIONS 94
6.1 U.S. 94
6.2 EUROPEAN UNION (EU) 95
6.3 FRANCE 95
6.4 AUSTRALIA 95
6.5 SOUTH KOREA 95
?
7 MARKET OVERVIEW 96
7.1 DRIVERS 98
7.1.1 RISING NUMBER OF POPULATION SUFFERING FROM DEPRESSIVE DISORDER 98
7.1.2 INITIATIVES TAKEN BY MANUFACTURERS DUE TO GENETIC VARIABILITY 98
7.1.3 GROWING BIOTECHNOLOGY SECTOR ALONG WITH RISING HEALTHCARE EXPENDITURE 99
7.1.4 INCREASING INTEREST FOR PERSONALIZED AND PRECISION MEDICATION 99
7.2 RESTRAINTS 100
7.2.1 INSUFFICIENT CLINICAL VALIDATION 100
7.2.2 STIGMA AND PERCEPTION FOR MENTAL HEALTH 101
7.2.3 LACK OF REIMBURSEMENT 101
7.3 OPPORTUNITIES 102
7.3.1 ADVANCEMENTS IN GENETIC TESTING 102
7.3.2 EMERGING START-UPS BRANCHES INNOVATION 103
7.3.3 REDUCED HEALTHCARE COSTS THROUGH THE IMPLEMENTATION OF COST-SAVING MEASURES 103
7.4 CHALLENGES 104
7.4.1 RISING CONCERN REGARDING DATA PRIVACY AND SECURITY 104
7.4.2 SHORTAGE OF SKILLED HEALTHCARE PROFESSIONALS 105
8 GLOBAL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PRODUCT 106
8.1 OVERVIEW 107
8.2 CONSUMABLES 111
8.3 INSTRUMENTS 113
8.4 SOFTWARE AND SERVICES 114
9 GLOBAL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TEST TYPE 115
9.1 OVERVIEW 116
9.2 WHOLE GENOME SEQUENCING 119
9.3 CHROMOSOMAL ARRAY BASED TESTS 123
10 GLOBAL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE 125
10.1 OVERVIEW 126
10.2 ANXIETY 130
10.3 DEPRESSION 131
10.4 MOOD DISORDERS 132
10.5 BIPOLAR DISORDERS 133
10.6 EATING DISORDERS 134
10.7 PSYCHOTIC DISORDERS 135
11 GLOBAL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY GENE TYPE 136
11.1 OVERVIEW 137
11.2 CYP2C19 141
11.3 CYP2C9 AND VKORC1 142
11.4 CYP2D6 143
11.5 HLA-B 144
11.6 HTR2A/C 145
11.7 HLA-A 146
11.8 CYP3A4 147
11.9 SLC6A4 148
11.10 MTHFR 149
11.11 COMT 150
11.12 OTHERS 151
12 GLOBAL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY PATIENT TYPE 152
12.1 OVERVIEW 153
12.2 ADULT 157
12.3 GERIATRIC 158
12.4 CHILD 159
13 GLOBAL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER 160
13.1 OVERVIEW 161
13.2 HOSPITAL AND CLINICS 164
13.3 DIAGNOSTICS LABORATORIES 166
13.4 ACADEMIC AND RESEARCH INSTITUTES 167
13.5 OTHERS 168
14 GLOBAL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL 169
14.1 OVERVIEW 170
14.2 DIRECT TENDER 174
14.3 THIRD PARTY DISTRIBUTION 175
14.4 HOSPITAL PHARMACY 176
14.5 OTHERS 177
15 GLOBAL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY REGION 178
15.1 OVERVIEW 179
15.2 NORTH AMERICA 183
15.2.1 U.S. 190
15.2.2 CANADA 197
15.2.3 MEXICO 204
15.3 EUROPE 211
15.3.1 GERMANY 220
15.3.2 FRANCE 228
15.3.3 U.K. 236
15.3.4 ITALY 244
15.3.5 RUSSIA 252
15.3.6 SPAIN 260
15.3.7 TURKEY 268
15.3.8 NETHERLANDS 276
15.3.9 SWITZERLAND 284
15.3.10 POLAND 292
15.3.11 HUNGARY 300
15.3.12 AUSTRIA 308
15.3.13 NORWAY 316
15.3.14 IRELAND 324
15.3.15 LITHUANIA 332
15.3.16 REST OF EUROPE 340
15.4 ASIA-PACIFIC 341
15.4.1 JAPAN 348
15.4.2 CHINA 355
15.4.3 SOUTH KOREA 363
15.4.4 INDIA 371
15.4.5 AUSTRALIA 379
15.4.6 SINGAPORE 387
15.4.7 THAILAND 395
15.4.8 MALAYSIA 403
15.4.9 INDONESIA 411
15.4.10 PHILIPPINES 419
15.4.11 VIETNAM 427
15.4.12 REST OF ASIA-PACIFIC 435
?
15.5 MIDDLE EAST AND AFRICA 436
15.5.1 SOUTH AFRICA 443
15.5.2 SAUDI ARABIA 450
15.5.3 U.A.E. 456
15.5.4 ISRAEL 462
15.5.5 EGYPT 469
15.5.6 REST OF MIDDLE EAST AND AFRICA 476
15.6 SOUTH AMERICA 477
15.6.1 BRAZIL 484
15.6.2 ARGENTINA 491
15.6.3 PERU 498
15.6.4 REST OF SOUTH AMERICA 505
16 GLOBAL PHARMACOGENETICS TESTING IN PSYCHIATRY/DEPRESSION MARKET: COMPANY LANDSCAPE 507
16.1 COMPANY SHARE ANALYSIS: GLOBAL 507
16.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 508
16.3 COMPANY SHARE ANALYSIS: EUROPE 509
16.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 510
17 SWOT ANALYSIS 511
18 COMPANY PROFILES 512
18.1 THERMO FISHER SCIENTIFIC INC. 512
18.1.1 COMPANY SNAPSHOT 512
18.1.2 RECENT FINANCIALS 513
18.1.3 COMPANY SHARE ANALYSIS 513
18.1.4 PRODUCT PORTFOLIO 514
18.1.5 RECENT DEVELOPMENT 516
18.2 ILLUMINA, INC. 517
18.2.1 COMPANY SNAPSHOT 517
18.2.2 REVENUE ANALYSIS 517
18.2.3 COMPANY SHARE ANALYSIS 518
18.2.4 PRODUCT PORTFOLIO 518
18.2.5 RECENT DEVELOPMENTS 519
18.3 MYRIAD GENETICS, INC. 520
18.3.1 COMPANY SNAPSHOT 520
18.3.2 REVENUE ANALYSIS 520
18.3.3 COMPANY SHARE ANALYSIS 521
18.3.4 PRODUCT PORTFOLIO 521
18.3.5 RECENT DEVELOPMENTS 522
18.4 SONIC HEALTHCARE LIMITED 523
18.4.1 COMPANY SNAPSHOT 523
18.4.2 REVENUE ANALYSIS 523
18.4.3 COMPANY SHARE ANALYSIS 524
18.4.4 PRODUCT PORTFOLIO 524
18.4.5 RECENT DEVELOPMENT 524
18.5 QIAGEN 525
18.5.1 COMPANY SNAPSHOT 525
18.5.2 REVENUE ANALYSIS 525
18.5.3 COMPANY SHARE ANALYSIS 526
18.5.4 PRODUCT PORTFOLIO 526
18.5.5 RECENT DEVELOPMENTS 527
18.6 AB-BIOTICS, S.A. 529
18.6.1 COMPANY SNAPSHOT 529
18.6.2 PRODUCT PORTFOLIO 529
18.6.3 RECENT DEVELOPMENTS 530
18.7 BIOGENIQ INC. 531
18.7.1 COMPANY SNAPSHOT 531
18.7.2 PRODUCT PORTFOLIO 531
18.7.3 RECENT DEVELOPMENT 532
18.8 CASTLE BIOSCIENCE, INC. 533
18.8.1 COMPANY SNAPSHOT 533
18.8.2 REVENUE ANALYSIS 533
18.8.3 PRODUCT PORTFOLIO 534
18.8.4 RECENT DEVELOPMENTS 534
18.9 CORIELL LIFE SCIENCES 535
18.9.1 COMPANY SNAPSHOT 535
18.9.2 PRODUCT PORTFOLIO 535
18.9.3 RECENT DEVELOPMENTS 535
18.10 DYNAMIC DNA LABORATORIES 537
18.10.1 COMPANY SNAPSHOT 537
18.10.2 PRODUCT PORTFOLIO 537
18.10.3 RECENT DEVELOPMENT 537
18.11 EUROFINS SCIENTIFIC 539
18.11.1 COMPANY SNAPSHOT 539
18.11.2 REVENUE ANALYSIS 540
18.11.3 PRODUCT PORTFOLIO 540
18.11.4 RECENT DEVELOPMENTS 541
?
18.12 GENELEX (SUBSIADIARY OF INVITAE CORPORATION.) 542
18.12.1 COMPANY SNAPSHOT 542
18.12.2 REVENUE ANALYSIS 542
18.12.3 PRODUCT PORTFOLIO 543
18.12.4 RECENT DEVELOPMENT 543
18.13 GENEWIZ (PART OF AZENTA LIFE SCIENCES) 544
18.13.1 COMPANY SNAPSHOT 544
18.13.2 REVENUE ANALYSIS 544
18.13.3 PRODUCT PORTFOLIO 545
18.13.4 RECENT DEVELOPMENT 545
18.14 GENOMIND, INC. 546
18.14.1 COMPANY SNAPSHOT 546
18.14.2 PRODUCT PORTFOLIO 546
18.14.3 RECENT DEVELOPMENTS 547
18.15 GENXYS 548
18.15.1 COMPANY SNAPSHOT 548
18.15.2 PRODUCT PORTFOLIO 548
18.15.3 RECENT DEVELOPMENTS 549
18.16 HEALTHSPEK 551
18.16.1 COMPANY SNAPSHOT 551
18.16.2 PRODUCT PORTFOLIO 551
18.16.3 RECENT DEVELOPMENT 551
18.17 HUDSONALPHA 552
18.17.1 COMPANY SNAPSHOT 552
18.17.2 PRODUCT PORTFOLIO 552
18.17.3 RECENT DEVELOPMENT 553
18.18 MD LABS 554
18.18.1 COMPANY SNAPSHOT 554
18.18.2 PRODUCT PORTFOLIO 554
18.18.3 RECENT DEVELOPMENT 554
18.19 ONEOME, LLC 555
18.19.1 COMPANY SNAPSHOT 555
18.19.2 PRODUCT PORTFOLIO 555
18.19.3 RECENT DEVELOPMENTS 556
18.20 PACBIO 558
18.20.1 COMPANY SNAPSHOT 558
18.20.2 REVENUE ANALYSIS 558
18.20.3 PRODUCT PORTFOLIO 559
18.20.4 RECENT DEVELOPMENTS 559?
19 QUESTIONNAIRE 561
20 RELATED REPORTS 565

Not Sure / Need Reassuring
- Confirm Content
  - Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
    
    Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
    
    Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
    
    Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
- Sample Pages
  - With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
    
    It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
    
    To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
- Check for Alternatives
  - Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
    
    To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
Prices / Formats / Delivery
- Prices
  - All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
    
    Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
- Discounts
  - As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
    
    Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
    
    To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
- Available Currencies
  - Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
    
    Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
    
    To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
- Licenses
  - License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
    
    If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
- Global Site License
  - The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
    
    It is important to note that this may exclude Parent Companies or Subsidiaries.
    
    If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
- Formats
  - The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
    
    If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
- Delivery
  - Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
    
    Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
    
    If a delay in delivery is expected you will be informed about it immediately.
- Shipping Charges
  - As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
    
    If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
Ordering
- By Credit Card
  - We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
    
    Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
    
    For more information on PayU please visit: https://www.payu.pl/en/about-us
- By Money Transfer
  - If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
    
    With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
Security
- Website security
  - We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
    
    Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
- Credit Card Security
  - We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
    
    PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.